The recent patent expiry of several blockbuster drugs has presented specialized active pharmaceutical ingredients (API) manufacturers with ample opportunities for expansion all over the world. The bioactive portions of any drug are made up of APIs. The U.S. FDA defines APIs as a material or an amalgam of materials utilized in the manufacture of a drug and one that becomes an active ingredient of the drug upon production. APIs present patients with health benefits and assist in diagnosing, preventing, and curing diseases, though the result of and reactions to the drug vary from patient to patient depending on the dosage consumed.

Browse Full Global API Market Report With Complete TOC @ http://www.transparencymarketresearch.com/active-pharmaceutical-ingredients.html


In the recent past, the increase in abbreviated new drug applications has stimulated the demand for APIs. Additionally, several Indian pharmaceutical companies are joining the rapidly growing global API market. However, the stern regulatory policies in the European Union are restricting the rise of this market.

In 2013, the global API market had reached a value of US$119.7 billion. By 2020, the market is estimated to be worth US$185.9 billion, developing at a CAGR of 6.5% during the period from 2014 to 2020.

In-house API manufacturing Market in Declining Phase Due to High Level of Competition

The captive or in-house API manufacturing market and the API contract manufacturing market are the segments of the global API market based on the type of manufacturing. Hitherto, the captive API manufacturing market was the dominant segment, but, at present, the market is losing ground owing to the high level of competition coupled with decreased profitability. Correspondingly, the API contract manufacturing market is registering impressive growth.

Based on the types of API, this market is classified into the synthetic chemical API market and the biological API market, in which the biological API market is undergoing major expansion on account of the attention giant pharma companies have started to pay to this market segment.

Browse Full Press Release Report:
http://www.transparencymarketresearch.com/pressrelease/active-pharmaceutical-ingredients.htm


The API market is dominated by generic prescriptions drugs based on the types of drugs and, owing to the global volume rise in generic prescription drugs, the demand for APIs is expected to witness a swift increase across the globe.

Apart from this, the oncology drugs market is likely to report the fastest growth in the global API market in terms of therapeutic area. The growth of this market is expected to boost demand for APIs to a large extent.

API market in North America to Maintain its Dominance

The global market for API is spread across North America, Europe, Asia Pacific, and Rest of the World, wherein the market is led by North America on the account of the increasing demand for APIs in drug formulations and the rise in R&D programs. Analysts expect the region to maintain its dominance in the near future. In response to high medical and healthcare costs in the U.S., the preference for generic medicines is on the rise, fueling growth of the API market in this region. The API market in Asia Pacific stands at the second position in the geographical hierarchy of the global market, due to the presence of generic medicine producers in large numbers.

The major players in the global API market are Actavis plc, Boehringer Ingelheim Group, BASF SE, Cambrex Corporation, Hospira, Inc., Dr. Reddy's Laboratories Ltd., Lonza Group, Novartis International AG, Mylan, Inc., Pfizer, Inc., WuXi Apptec, and Teva Pharmaceutical Industries Ltd. However, the market consists of more than 2,500 participants, making it highly fragmented in nature. The recent approval of ZarxioTM (first biosimilar in the U.S.) of Sandoz - the generic pharma division of Novartis - is expected to add significantly to overall revenue generated in the global API market.

Request a Brochure of this Report
http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=1690

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

The global market for peptide therapeutics market derives much of its demand from the treatment of cancer and diabetes. The rising incidence of these diseases is making way for the advancement of peptide drugs, which in turn is propelling the global peptide therapeutics market. Additionally, the technical advancements in peptide drugs have resulted in a reduction in total production cost, fueling the production process of new peptide drugs.

Browse Full Global Peptide Therapeutics Market Report With Complete TOC @ http://www.transparencymarketresearch.com/peptide-therapeutics-market.html


On the other hand, API manufacturers are facing a tough challenge from the complex structure of peptides. Other than this, the lack of regulatory standards to arbitrate developments in peptide drugs is also hampering the growth of the peptide therapeutics market. However, biotech enterprises are identifying prospects for future growth in collaboration with major pharmaceutical firms across the globe.The global peptide therapeutics market is expected to expand at a CAGR of 2.8% during the period from 2014 to 2020 in order to reach US$23.7 billion by 2020. The market had reached a value of US$18.9 billion in 2013.

Market for Respiratory Disorders Poised to Grow at Highest CAGR between 2014 and 2020

Peptide therapeutics find application in the treatment of various kinds of ailments such as cardiovascular, nervous, gastrointestinal, respiratory, metabolism-related, in addition to cancer, various infections, and pain. The cancer market was the dominant application segment of the peptide therapeutics market in 2013. However, the respiratory disorder market segment is projected to develop at the highest CAGR during the period from 2014 to 2020 owing to the recent approval of lucinactant, sold under the brand name Surfaxin.

The global peptide therapeutics market is analyzed on three fronts: Route of administration, marketing status, and regional distribution of the global industry. Based on route of administration, parenteral and oral are the two segments of this market, while branded peptide therapeutics and generic peptide therapeutics are the segments of the global market on the basis of marketing status. The market for generic peptides is expected to do well in the next few years on account of patent expirations expected in the branded peptide market in the near future.

Asia Pacific to Report Highest Compound Annual Growth Rate from 2014 to 2020

Regionally, the global peptide therapeutics market is distributed among North America, Europe, Asia Pacific, and the Rest of the World, wherein the global market is dominated by the North American and European markets, which jointly occupy over 60% of the global market. However, in spite of the dominance of these regions in the global market, the peptide therapeutics market in Asia Pacific is poised to grow at the highest CAGR during the period from 2014 to 2020.The peptide therapeutics market in Asia Pacific is majorly driven by the rapid growth of this market in China, India, and Japan. The rise in economic stability and increased awareness pertaining to the treatment of various diseases are the major factors fueling the growth of the market in this region.

Browse Full Press Release Report: http://www.transparencymarketresearch.com/pressrelease/peptide-therapeutics-market.htm

Japan is the second largest market in the global individual pharmaceutical industry, whereas China and India have a huge population pool suffering from various diseases and ailments that are cured with the help of peptide therapeutics. These factors are expected to establish Asia Pacific as the most promising market for peptide therapeutics in the near future. China and India are also emerging as some of the largest peptide API suppliers in the world.

Amgen, Inc., Bachem Holding AG, AstraZeneca Plc, CordenPharma Int. GmbH, Ipsen S.A., Eli Lilly and Co., Lonza Group Ltd., Novartis AG, Merck & Co., Inc., Novo Nordisk A/S, Roche Holdings AG, PolyPeptide Group, Sanofi, Millennium Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., and Takeda Pharmaceutical Co. Ltd. are the major enterprises working in the global peptide therapeutics industry. The market is mostly concentrated as Takeda, Teva, and Novo Nordisk collectively hold more than 50% of the overall peptide therapeutics market.

The forthcoming patent expiry of Copaxone by Teva and Velcade by Millennium Pharma and the projected launch of their generic alternatives are expected to change the dynamics of the global peptide therapeutics market in the near future.

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=418

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector - such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Dilated cardiomyopathy is a condition strongly related to heart attacks, in which the ventricles are enlarged, resulting in a thinning of cardiac walls, and insufficient pumping of blood. Dilated cardiomyopathy can occur at any age, though it is most common in the 20-40 demographic. One of the major reasons of dilated cardiomyopathy is genetic. Some other factors that can cause dilated cardiomyopathy are thyroid disorders, viral infections of the heart, diabetes, alcoholism, and heart valve malformations.

Browse Full Global Dilated Cardiomyopathy Therapeutics Market Report With Complete TOC @ http://www.transparencymarketresearch.com/dilated-cardiomyopathy-market.html


Angiotensin II Receptor Blockers Held Largest Share of Dilated Cardiomyopathy Therapeutics Market in 2013 by Revenue

The dilated cardiomyopathy therapeutics market worldwide is segregated on the basis of drug class, pipeline drugs, and geography. The dilated cardiomyopathy therapeutics market globally in terms of drug class is broadly classified as angiotensin-converting enzyme (ACE) inhibitors, beta blockers, aldosterone antagonists, and angiotensin II receptor blockers (ARBs). Of all the drug class, angiotensin II receptor blockers held the largest share of the dilated cardiomyopathy therapeutics market in 2013 by revenue, followed by beta blockers.

The high demand for the leading drugs for the treatment of dilated cardiomyopathy from developed regions such as Europe and North America is a reason for the large market shares of these classes of drugs. When used in combination either with ACE or ARBs, aldesterone antagonist drugs have proven to have a positive impact on the reduction of progressive conditions such as Duchenne muscular dystrophy (DMD).

The global dilated cardiomyopathy therapeutics market was worth US$651.0 million in 2013. By 2020, the global dilated cardiomyopathy therapeutics market is projected to be worth US$328.6 million which shows a decline of 7% CAGR from 2014 to 2020.

Clinical Trials May Halt Expected Reduction of Dilated Cardiomyopathy Therapeutics Market

The dilated cardiomyopathy therapeutics market worldwide is driven by growing incidence of congestive heart failure which is significantly related with DCM. On a global scenario, dilated cardiomyopathy is associated to 30% to 40% for congestive heart failure cases every year. Due to the growing incidence of congestive heart failure worldwide, several companies have initiated clinical trials for the advancement of therapeutics for dilated cardiomyopathy.

Some of the clinical trials undertaken are a phase II study by Array BioPharma in 2015 for its drug class ARRY-371797, a phase II study by Celladon Corporation in 2014 for its drug class MYDICAR. The dilated cardiomyopathy therapeutics market is expected to get a boost on the successful completion of these clinical trials. However, implantable devices such as heart pumps, pacemakers, and advancement in gene therapy will restrain the growth of dilated cardiomyopathy therapeutics market.

Browse Full Press Release Report :
http://www.transparencymarketresearch.com/pressrelease/dilated-cardiomyopathy-market.htm

North America Leads Global Dilated Cardiomyopathy Therapeutics Market

According to geographical segmentation, the dilated cardiomyopathy therapeutics market is divided into four regions, which are Asia Pacific, Europe, North America, and Rest of the World (RoW). North America held the largest share of the dilated cardiomyopathy therapeutics market in 2013 owing to rising cases of heart diseases and acceptance for branded drugs.

The U.S. and Canada make up the dilated cardiomyopathy therapeutics market in North America. The prevalence of DCM in the U.S. is high; 5-8 people out of every 100,000 are diagnosed with DCM. In Canada, heart failure accounts for 9% of total deaths in the country, which is driving the dilated cardiomyopathy therapeutics market in North America.

In Europe, countries such as Spain, Germany, the U.K., and Italy contribute significantly towards the growth of the dilated cardiomyopathy therapeutics market. The dilated cardiomyopathy therapeutics market is growing in Asia Pacific and Rest of the World (RoW) owing to rising economic power, higher incomes, and growing demand for generic drugs.

Some of the key players in the dilated cardiomyopathy therapeutics market are Teva Pharmaceutical Industries Ltd , Merck & Co., Inc., Array BioPharma, Inc., Celladon Corporation, GlaxoSmithKline plc, Pfizer, Inc., Janssen Pharmaceuticals, Inc., Novartis International AG, Sanofi S.A., AstraZeneca plc and Vericel Corporation.

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=2293

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Kidney cancer is considered to be one of the 10 most common cancers affecting men and women across the globe. While the risk of kidney cancer is higher in men than in women, there are numerous factors that determine the risk of cancer. The two main types of kidney cancer are renal cell carcinoma (RCC) and transitional cell carcinoma (TCC), and kidney cancer drugs are generally administered to patients of stage four, advanced RCC.

Browse Full Global Kidney Cancer Drugs Market Report With Complete TOC @ http://www.transparencymarketresearch.com/kidney-cancer-drugs-market.html


According to the American Cancer Society, in the year 2015, approximately 61,560 new cases of kidney cancer will be registered in the United States alone, of which 23,290 will be women and 38,270 will be men. Out of these, around 14,080 people will die from the disease in 2015, of which 5,010 will be women and 9,070 will be men.

The U.S. National Cancer Institute states that kidney cancer is more common among American Indian, African American, and Alaska Native populations. This makes North America a rather large and lucrative market for kidney cancer drugs.

Votrient: Most promising commercially available kidney cancer drug

There are a number of kidney cancer drugs that are prescribed, used, and commercially available today. Some of the major brands are Votrient (Pazopanib), Inlyta (Axitinib), Proleukin (Aldesleukin), Afinitor (Everolimus), Sutent (Sunitinib), Nexavar (Sorafenib), Torisel (Temsirolimus), and Avastin (Bevacizumab).

Of these, Sutent (Sunitinib) dominated the kidney cancer drugs market in 2013, accounting for 30% of the revenue share. Often considered to be the first line of treatment for renal cell carcinoma (RCC), Sutent is one of the most studied kidney cancer drugs for multiple indications. However, owing to its relatively high price, this drug is expected to register a rather meager growth rate of 1.1% from 2012 to 2016 and 2.1% from 2016 to 2020.

Votrient (Pazopanib), on the other hand, is projected to be the most promising kidney cancer drug during the forecast period and will witness the strongest growth between 2012 and 2020. According to a report by Transparency Market Research (TMR), Votrient is estimated to grow at an outstanding CAGR of 41.7% from 2012 to 2016, and 8.9% from 2016 to 2020.

Browse Full Press Release Report : http://www.transparencymarketresearch.com/pressrelease/kidney-cancer-drugs-market.htm

U.S. largest pharmaceutical market in the world

The global kidney cancer drugs market is divided into four key geographic regions: North America, Europe, Asia-Pacific, and Rest of the World. The growing prevalence of kidney cancer makes North America the leading market for kidney cancer drugs; revenue-wise, this region held more than 45% of the total share in 2013. Split into Canada and the United States, the North America market is driven by a growing patient pool, commercial availability of leading drugs for the treatment of kidney cancer, a strong healthcare insurance base, and impressive healthcare systems customized for the pharmaceutical sector. The U.S. accounted for 90% of the North America kidney cancer drugs market.

The APAC region has also proved to be a lucrative market for kidney cancer drugs owing to a rising geriatric population, growing prevalence of kidney cancer, and economic recovery and growth in countries such as China, Japan, Australia, and New Zealand. Registering a 6% growth rate, the Asia-Pacific market for kidney cancer drugs is anticipated to be the fastest growing regional segment during the forecast period.

Market to register healthy growth rate owing to intense competition

The recently-published TMR report has indicated that the market for kidney cancer drugs is characterized by strong competition among industry participants. With the global market being immensely consolidated, there are only a handful of established pharmaceutical companies who dominate the kidney cancer drugs market. Some of the principal players operating in the market are GlaxoSmithKline, plc, F. Hoffmann-La Roche, Ltd., Pfizer, Inc., Bayer AG, and Novartis AG. Among these, Pfizer was the largest maker of kidney cancer drugs in the world and held more than 40% of the total market share in 2013.

The report states that this concentration of power in the hands of a few contributes to the growth of the kidney cancer drugs market. In 2013, the global market was valued at US$2.6 billion and this is estimated to reach US$4.5 billion by 2020, expanding at a compound annual growth rate of 6.6% till 2020.

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=537

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

According to a new report published by Transparency Market Research "Meningococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022," the meningococcal vaccines market was valued at USD 1.5 billion in 2013 and is expected to reach a value of USD 4.4 billion in 2022, growing at a CAGR of 12.4% from 2014 to 2022.

Browse the full Meningococcal Vaccines Market Report at http://www.transparencymarketresearch.com/meningococcal-vaccines-market.html


Meningococcal disease is caused by the bacterium Neisseria meningitidis and occurs sporadically throughout the world with seasonal variations. It accounts for a proportion of endemic bacterial meningitis, which can progress very rapidly leading to death within 24 hours from the onset of symptoms. The disease is often misinterpreted as common flu in most of the cases. Five out of the several serogroups are known to cause meningococcal disease. The serogroups responsible for causing the disease comprise A, B, C, Y and W-135. The causative agent N. meningitidis is commonly found in the nasopharynx of humans and gets transmitted through droplet inhalation by means of close contact such as exposure to smokers, crowded living conditions such as dormitories, certain inherited disorders of the immune system, functional/anatomical asplenia or through intimate oral contact among others. According to the European Federation of Pharmaceutical Industries and Association, every year, meningitis affects almost 500,000 people globally, primarily affecting toddlers, infants and young adults, due to weaker immune system.

The global market for meningococcal vaccines is segmented broadly into vaccine types namely, polysaccharide, conjugate, combination and Men B vaccines. The report also provides analysis for vaccine under development, NmVac4-DT by JN- International that is expected to be commercialized during the forecast period 2014 to 2022. The vaccine types are further segmented by different brands available in the market. The conjugate vaccines segment is likely to lead the overall meningococcal vaccines market in terms of revenue, which is estimated to be worth USD 2,655.0 million by 2022 at a CAGR of 8.9%. According to Department of Health, U.K., Bexsero is the first serogroup B vaccine to be incorporated into the national immunization program and is expected to be available in the market for sales post settle of price negotiations. The U.S. FDA recently approved two Men B vaccines: Trumenba by Pfizer in October 2014 and Bexsero by Novartis in January 2015.

Browse the full Press release Report :
http://www.transparencymarketresearch.com/pressrelease/meningococcal-vaccines-market.htm

The market for meningococcal vaccines is largely driven by increasing government intervention in reforming the healthcare infrastructure and incorporation of legislations specific to meningococcal vaccination. The public-private partnerships for conducting research and development, and manufacturing of quality vaccines at an affordable price are also contributing positively in driving market growth. Awareness campaigning from government and non-profit organizations, and obligatory immunization for individuals heading to Mecca (for Hajj pilgrimage) and the South African meningitis belt will also contribute to growth of this market. High cost of few but vital vaccines, such as Bexsero, and need for efficient cold chain logistics to maintain safety and efficacy of the vaccine are expected to be some of the major factors posing a challenge to the adequate uptake of these vaccines.

meningococcal-vaccines-market


The key players dominating the global meningococcal vaccines market include Sanofi Pasteur (the vaccine division of Sanofi SA), Novartis International AG and GSK plc. These players account for more than 90% of the meningococcal vaccines market. Players such as Serum Institute of India Ltd., JN International Medical Corporation, Biomed Pvt. Ltd., Nuron Biotech and Baxter account for the remaining market share.

The global meningococcal vaccines market is segmented as follow:

Meningococcal Vaccines Market, by Type
Polysaccharide Vaccines, by Brand
Menomune
Mencevax
NmVac4
Others
Quadri Meningo
Bi Meningo
Conjugate Vaccines, by Brand
Menactra
Menveo
NeisVac-C
Nimenrix
Meningitec
Menjugate
MenAfriVac
Combination Vaccines, by Brand
MenHibrix
Menitorix
NmVac4-DT
Men B Vaccines, by Brand
Bexsero
Trumenba
Meningococcal Vaccines Market, by Geography
North America
U.S.
Canada
Europe
U.K.
Germany
Rest of Europe
Asia Pacific
Japan
Australia
Rest of Asia Pacific
Rest of the World
Latin America
Africa
Rest of RoW

Request a Brochure of this Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=1666

 
About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

According to a new market report published by Transparency Market Research "Alternative Sweetener Market - Global Industry Analysis, Size, Share, Growth and Forecast 2015 - 2021", global alternative sweetener market was valued at USD 11,538.6 million in 2014 and is expected to reach USD 15,466.7 million by 2021, growing at a CAGR of 4.2% from 2015 to 2021. North America dominated the global alternative sweetener market in terms of demand over the forecast period. Further, North America is expected to be the most promising market for alternative sweetener in the near future.

Browse the full Alternative Sweetener Market - Global Industry Analysis, Size, Share, Growth and Forecast 2015 - 2021 report at http://www.transparencymarketresearch.com/alternative-sweetener-market.html


The global alternative sweetener market is primarily driven by rise in demand for healthier low-calorie food and beverages. Furthermore, rising prices of sugar have boosted the growth of the alternative sweetener market. However, the restraining factor of the alternative sweetener market is the food and safety regulations and excess consumption of sugar substitutes which causes certain side effects such as cancer, obesity and cardiovascular diseases among others serious health problems.

The high intensity sweetener (HIS) held the largest market share in 2014. High intensity sweetener is expected to grow at a CAGR of 3.4% from 2015 to 2021. The high fructose syrup (HFS) held the second largest market share of alternative sweetener in 2014, followed by high intensity sweetener. The fastest growing market segment, low intensity sweetener in overall alternative sweetener market is expected to grow at a CAGR of 7.1% over the forecast period.

alternative-sweetener-market

North America is the market leader for alternative sweetener, growing at a CAGR of 3.6% from 2015 to 2021. Asia Pacific is the other major region where alternative sweetener sales are very high and the region is expected to grow with a stable CAGR, between 2015 to 2021, followed by Europe. In North America, the U.S. and Mexico dominated the market revenue for alternative sweetener. In Asia Pacific, China and India are the major markets growing at a CAGR of 3.4% and 6.0% respectively from 2015 to 2021. In Europe, Germany was the most attractive market of alternative sweetener in terms of revenue in 2014. Though Asia Pacific held the second position in global alternative sweetener market, and still it is expected to grow with a high CAGR as compare to Europe over the forecast period.

Tate & Lyle Plc, Cargill, Incorporated, Ajinomoto Co., Inc., Archer-Daniels-Midland Company, Ingredion Incorporated, Roquette Frères S.A., and NutraSweet Company are some of the key players operating in alternative sweetener market globally.

This research study is specially designed to estimate and analyze the demand and performance of alternative sweetener in a global scenario. Under the scope of the report, all the major product segments of the alternative sweetener market are covered. In addition, the report provides historical data, business strategies of major market players, statistically refined forecast and in-depth analysis for the segments covered. The research study provides detail analysis of alternative sweetener ingredients and alternative sweetener product manufacturers, sales of alternative sweetener based products and trend analysis by segments and demand by geography. The scope of the study presents a comprehensive evaluation of the stakeholder strategies and winning imperatives for them by segmenting the alternative sweetener market as below:


Browse Full Press Release :
http://www.transparencymarketresearch.com/pressrelease/alternative-sweetener-market.htm


Global alternative sweetener market has been segmented as follows:
Global alternative sweetener market, by product type
High Fructose Syrup (HFS)
High Intensity Sweetener (HIS)
Low Intensity Sweetener (LIS)
Global alternative sweetener market, by application
Food
Beverages
Others (including pharmaceuticals and personal care etc)
In addition, the report provides cross-sectional analysis of all the above segments with respect to the following geographies:
Global alternative sweetener, by geography
North America
U.S.
Canada
Rest of North America
Europe
Germany
U.K.
France
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
Rest of Europe
Rest of the World (RoW)
Latin America
Middle East
Other countries in RoW

Request a Brochure of this Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=4792


About Us

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Mr. Atil Chaudhari
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Paper-based records are being phased out at a rapid pace in the healthcare industry, and paperless healthcare systems are filling this void. Digitization and virtualization are the two biggest trends and they have created a whole new electronic health records (EHR) market within the global healthcare industry. The ball has been set rolling with over 54% physicians in the United States adopting electronic health record systems, as of 2011. These estimates were reported by the U.S. Centers for Disease Control (CDC). In the same year, 50% of physicians who were not already using an EHR system said that they planned to invest in one within the next twelve months.

Browse Full Global Electronic Health Records Market Report With Complete TOC @ http://www.transparencymarketresearch.com/electronic-health-records-market.html


A similar change is taking place in the United Kingdom, as by 2018, the National Health Service (NHS) is slated to go entirely paperless. Thus, the market for electronic health records in the United Kingdom looks promising.

Market Forecasts in Numbers: The Electronic Health Records Market will Show a 6.4% CAGR

According to the findings of Transparency Market Research (TMR), a U.S.-based market intelligence firm, the global electronic health records (EHR) market is projected to show a CAGR of 6.4% between 2014 and 2020. This marks an imminent phase of moderate growth that will largely be seen in traditional markets.

The global EHR market can be segmented based on the way the EHR systems are installed as web-based or client server-based. The latter accounted for the better part of the market share in 2013, when considered from the revenue perspective. But, the CAGR of web-based EHR systems is expected to be higher through 2020 largely because such systems have only a nominal upfront cost, and do not call for the installation of hardware systems and components.

The market for electronic health records (EHR) can also be classified based on the end-users that purchase such systems; the market is thus composed of hospitals and ambulatory centers. The former was the dominant segment by revenue in 2013, as 90% of all hospitals in the United States were found to have a certified EHR system in 2013. This estimate was provided by the Annual IT Health Survey conducted by the American Hospital Association (AHA). Most of these hospitals, however, opt for a client server-based electronic health record system simply because it facilitates faster data transmission between multiple facilities when compared with cloud-based electronic health record systems. However, the future growth prospects of the ambulatory centers end-user type are expected to be most promising. The key reason behind this is the higher penetration of cloud-based EHR solutions providers in the market. With minimal or no upfront costs to ambulatory centers, cloud-based EHR systems offer a great solution. Many government health agencies and not-for-profit health organizations have been putting pressure on hospitals and physicians to switch over to electronic health records.

Europe and North America Will Continue Dominance in the Electronic Health Records (EHR) Market to 2020

About 42% of the total global EHR market was held by North America in 2013. The second largest market was that of Europe, which was followed by Asia Pacific. Till 2020, these rankings are unlikely to change, as North America will continue to hold a lead over other regional markets supported by solid government funding.

However, the EHR market is gathering steam in Australia and New Zealand as well as Asian countries such as China, Japan and India. The three Asian economies will exhibit the fastest growth, and will grow consistently to contribute to a major chunk of the market revenues by 2020.

The leaders in the electronic health records market have a grip on over 50% of all revenues. These leading players include: Cerner Corporation, Allscripts Healthcare Solutions, Inc., McKesson Corporation, GE Healthcare and Epic Systems.


Browse Full Press Release Report: http://www.transparencymarketresearch.com/pressrelease/electronic-health-records-market.htm

Geographically, the global EHR market has been classified into four major regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each of these regions along with the CAGR has been provided in the report.

The study on the global EHR market also suggests a list of recommendations for new companies willing to enter the market and for existing companies to accentuate revenue shares. The report concludes with the profiles of major players in the global EHR market such as Allscripts Healthcare Solutions, Inc., Cerner Corporation, Epic Systems, Medical Information Technology, Inc. (MEDITECH), McKesson Corporation, NextGen Healthcare (Quality Systems, Inc.), Computer Programs and Systems, Inc. (CPSI), GE Healthcare and eClinicalWorks. Each company profile in the report provides information under the heads: company overview, financial overview, product portfolio, business strategies and recent developments.

The company overview section comprises basic information about the company such as major business areas, company's brief history and its establishment year, number of employees and geographical presence. In the financial overview section, annual revenue for the last three consecutive years (2011, 2012 and 2013) has been provided. The business strategies section mentions key strategies adopted by the company in the past to strengthen its position in the EHR market. The recent development section gives information about the recent happenings in the companies operating in the EHR market.

The global EHR market is segmented as follows:

Global EHR Market, by Installation Type
Web-based EHR System
Client Server-based EHR System
Global EHR Market, by End-user
Hospitals
Ambulatory Centers
Global EHR Market, by Geography
North America
Europe
Asia-Pacific
Rest of the World (RoW)

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=4153


About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector - such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

The expanding diabetic population is one of the significant matters of concern universally. With the developing mindfulness and data with regard to preventive measures for diabetes, consumers are choosing diabetic food alongside pharmaceuticals. The diabetic population is expanding because of the occupied way of modern life and customers' inclination for convenient junk food. Moreover, the number of youths and kids diagnosed with juvenile diabetes is increasing because of the absence of a healthy eating regimen and physical activity. Thanks to rising health cognizance, consumers are indicating solid inclination for low-calorie nourishment products. Besides, many producers have extended their product portfolio to incorporate diabetic food products, with a specific end goal to pull in this growing niche of consumers.The global diabetic food market was valued at US$7,418.6 million in 2013 and is expanding at a CAGR of 5.9% between 2014 and 2020 is expected to reach US$11,098.0 million by 2020,

Browse Full Global Diabetic Food Market Research Report With Complete TOC @ http://www.transparencymarketresearch.com/diabetic-food-market.html


Rising Awareness about a Healthy Lifestyle: One of the Key Driving Factors Responsible for Mounting Demand for Diabetic Food

Some food producers have begun utilizing artificial sweeteners, such as aspartame, neo-tame, and acesulfame K in place of sugar. The wide range of diabetic food products on offer can be classified into dietary drinks, low-fat dairy items, low-calorie desserts, and jams. Moreover, food manufacturers are now extending their product portfolio to incorporate baked items and diabetic confectioneries, among others.

Rise in the global aging population is one of the central factors driving the market for diabetic food worldwide. In addition to this, rising awareness about a healthy lifestyle among the geriatric population is prompting an increment in the demand for diabetic food around the world.

Moreover, increasing consumer concern about adherence to healthy eating choices leading to changes in food preference is likewise boosting the demand from the diabetic food market. Moreover, increase in consumer mindfulness about health advantages associated with low-calorie diabetic food products is likewise pushing the development of the diabetic food market.

Browse Full Press Release Report:
http://www.transparencymarketresearch.com/pressrelease/diabetic-food-market.htm

North American Diabetic Food Market: Outstanding as the Most Dominant Market

The global diabetic food market, based on geography, is segmented into North America, Europe, Asia-Pacific, and Rest of the world. North America ruled the diabetic food market worldwide in 2013, trailed by Europe and Asia Pacific. Increasing disposable income is a major factor having a positive effect on the developing interest in diabetic food worldwide. Increasing awareness towards keeping up a healthy way of living is boosting the demand for diabetic foods in RoW. U.S. rules the diabetic food market in North America.

Expanding prevalence of high blood glucose levels and the growing aging population is producing a positive effect on the diabetic food market in the U.S. The U.K. and Germany ruled the diabetic food market in Europe. Rising awareness to develop a healthy lifestyle is likewise prompting a rise in demand for diabetic food products all around Europe. China and Japan drive the market for diabetic food in the region of Asia Pacific.

Expanding knowledge with respect to the advantages connected with diabetic food is one of the main factors inciting the demand for diabetic food in this region. This factor is also applicable to the Middle East and Africa, where a growing base of informed citizens is boosting the diabetic food market. Latin America and the Middle East dominate the business sector for diabetic food in Rest of the World.

Some of the leading diabetic food manufacturers in North America, Europe, Asia Pacific, and RoW include Unilever Plc, Nestle S.A., PepsiCo Inc., The Coca-Cola Company, Cadbury plc, Kellogg Company, Mars, Inc., Fifty 50 Foods, Inc., and David Chapman's Ice Cream Limited.


Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=b&rep_id=1828

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.


Contact

Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

According to a new market report published by Transparency Market Research "Antibacterial Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023," the global antibacterial drugs market was valued at USD 43.9 billion in 2014 and is estimated to reach USD 38.8 billion by 2023 at a CAGR of (1.3%) from 2015 to 2023.

Antibacterial drugs have been utilized by humans since the discovery of the first antibiotic penicillin in 1928 by Alexander Fleming and has evolved into a multi-billion dollar market. These drugs treat infectious diseases caused by gram positive, gram negative, aerobic and anaerobic bacteria that cannot be treated by any other method unlike other diseases, where substitute methodologies are available. This property has made antibacterial drugs an indispensable part of human health care. Over the period, the bacteria have genetically mutated giving rise to multi-drug resistant (MDR) variants. The prevalence of MDR bacterial infections is also on a hike; according to World Health Organization (WHO) in 2013, there were about 480 000 new cases of multidrug-resistant tuberculosis (MDR-TB); extensively drug-resistant tuberculosis (XDR-TB) has been identified in 100 countries. MDR-TB requires treatment courses that are much longer and less effective than those for non-resistant TB.

Browse the Antibacterial Drugs Market Report at http://www.transparencymarketresearch.com/antibacterial-drugs-market.html

Antibacterial drugs are classified into eight major classes, namely, aminoglycosides, B-Lactams, tetracyclines, sulfonamides, quinolones, macrolides, phenicols and miscellaneous antibacterials. The B-lactams class was the largest segment of the global antibacterial drugs market in 2014, with 58% share. Quinolones was identified as the second largest class, which held a share of 17% of the global antibacterial drugs market in 2014 and is expected to report a negative CAGR during the forecast period. This decline in revenue will be primarily witnessed due to sales erosion from patent expiries, evolution of resistant strains of bacteria and rising concerns regarding tendon ruptures and tendon damage from fluoroquinolones administration. However, the demand for macrolides and quinolones/fluoroquinolones classes will remain high during the forecast period, due to their usage in treating a large number of infections coupled with expected launch of pipeline drugs in these classes during the forecast period.

The key drugs in pipeline have been identified for this market (currently in phase III clinical trials) and sales forecast has been provided for those expected to be launched during the forecast period (2015 to 2022). These include solithromycin (Cempra, Inc.), VivaGel (SPL7013) (Starpharma Holdings Limited), surotomycin (Merck & Co.), MK-3415A (Merck & Co.) and others. These drugs promise to provide improved efficacy, shorter onset of action and fewer side effects as compared to the currently available antibacterial drugs. Hence, future commercialization of these drugs during the forecast period is anticipated to have a profound impact on the growth of the overall antibacterial drugs market.

AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly and Company, Forest Laboratories, Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer, Inc., and Sanofi are the major players operating in the global antibacterial drugs market. These players have worldwide presence in the pharmaceutical industry and are involved in constant competition with each other. Pfizer, Inc. was observed to be the leading player in the antibacterial drugs market. Major end-users for antibacterial drugs include hospitals, private clinics, physicians and patients.

Browse the full Antibacterial Drugs Market (By Class- Aminoglycosides, B-Lactams, Tetracyclines, Sulfonamides, Quinolones/ Fluoroquinolones, Macrolides, Phenicols and Miscellaneous

Browse the Press Release:http://www.transparencymarketresearch.com/pressrelease/antibacterial-drugs-market.htm


The global antibacterial drugs market has been segmented as below:

Global Antibacterial Drugs Market, by Drug Class, 2013 - 2023 (USD Million)
Aminoglycosides
B-Lactams
Tetracyclines
Sulfonamides
Quinolones/Fluoroquinolones
Macrolides
Phenicols
Miscellaneous Antibacterials
Pipeline Analysis of Antibacterial Drugs Market
Actoxumab/Aezlotoxumab, (MK-3415A)
Surotomycin (MK-4261)
Arikace
Cadazolid
Ciprofloxacin/Fluocinolone Acetonide
Zempia (E-101)
Carbavance (meropenem/RPX7009)
Ozenoxacin
RHB-105
SPL7013
Delafloxacin
Solithromycin (CEM-101)
Eravacycline
Delamanid
SYM-1219
Omadacycline (PTK-0796)
Plazomycin
Global Antibacterial Drugs Market, by Geography, 2013 - 2023 (USD Million)
North America
U.S.
Canada
Europe
U.K.
Germany
Rest of Europe
Asia-Pacific
China
Japan
Rest of Asia Pacific
Latin America
Brazil
Rest of Latin America
Rest of the World (RoW)

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1567



About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

According to a new market report published by Transparency Market Research "Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market - India Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" the sterilizers and surgical, dental care and equipment disinfectors market in India was valued at INR 806.0 Crore in 2013 and is estimated to reach a market worth of INR 1,390.2 Crore in 2020 increasing at a CAGR of 8.2% from 2014 to 2020.

Rising incidence of hospital acquired infectious diseases and increase in the number of surgeries in hospitals is expected to drive the sterilizers and surgical, dental care, and equipment disinfectors market in India. Factors that drive the growth of the sterilization equipment and disinfectants market in India are large pool of geriatric population, rise in prevalence of cancer and increasing number of hospital-acquired infections (HAIs). Furthermore, increase in per capita healthcare expenditure would also propel the growth of this market. According to Trading Economics, disposable personal income in India increased to approximately INR 80,663,730 million in 2012 from INR 71,787,870 million in 2011. Additionally, the market is likely to witness steady growth in technological advancements such as introduction of radiation-based sterilization techniques (gamma and E-beam sterilization) during the forecast period due to high product compatibility and low cost. Negligence towards sterilization measures in hospitals might restrain market growth. Moreover, increasing acceptance of single use and disposable medical device is another major restraint to the chemical sterilizers market.

sterilizers-surgical-dental-care-equipment-disinfectors-market

Government measures to provide adequate healthcare services in remote parts of nation have substantially increased the number of hospitals in the last few years. Furthermore, growing medical tourism in India is also driving the market growth. To further elucidate, heart bypass surgery in India costs USD 5,200 (approx. INR 3.3 Lakhs) while it costs USD 144,000 (Approx. INR 91 Lakhs) in the U.S. Low treatment cost in India is attracting patients across the world and is expected to drive growth of the sterilizers and surgical, dental care, and equipment disinfectors market during the forecast period. According to an article published by the Times of India in September 2014, India is among the top three medical tourism destinations in Asia, primarily due to low cost of treatment, availability of highly skilled specialists, and sophisticated health care infrastructure. However, growing inclination towards single use and disposable instruments due to its consistency and safety has affected the India sterilizers and surgical, dental care and equipment disinfectors market in last few years.

Chlorhexidine gluconate, alcohol, povidone-iodine, benzalkonium chloride, octenidine hydrochloride, ethyl-hexadecyl-dimethyl ammonium and others (aldehydes, hydrogen peroxide, hypochlorites and chlorine based disinfectors) collectively form the chemical formulations market; among which chlorhexidine gluconate based formulations accounted for the largest market share and is expected to lead the position during the forecast period due to the high safety, better efficacy and high usage adoption rate among hospitals and patients. Similarly, within the general hospitals application segment usage of chemical sterilizers and disinfectors were observed to be highest in wound care. Increasing number surgical procedures and rising number of trauma cases are few of the major factors that are boosting the application of sterilizers and disinfectors in wound care segment. Furthermore, within end-users segment operating rooms, ICUs and nursing tables segment accounted for the largest market share and is anticipated to lead the market during the forecast period due to high usage of chemical disinfectors used for disinfecting the equipment used during surgeries. Similarly, within the surgery stages segment post-operative surgery stage account for the largest market share due to the due to increasing risk of infection caused by a number of microbes, their growing drug resistance, and extended hospital stay after the surgery.

Key players profiled in this research report include 3M, Advanced Sterilization Products Services, Inc., Antrix Hygiene Ltd., Ipca Laboratories Ltd., Medi-Vet Animal Health, LLC, PSK Pharma Private Limited, Raman & Weil Pvt. Ltd., Ranbaxy Laboratories Ltd., Reckitt Benckiser Group plc, Sanosil Biotech Pvt. Ltd., Schülke India Pvt. Ltd., UPS Hygienes Pvt. Ltd., Win-Medicare Pvt. Ltd., and Zep Superior Solutions. The end-users (hospitals) profiled in this study are Apollo Hospitals Enterprise Ltd., Fortis Healthcare Limited, and Wockhardt Hospitals.

Browse the full Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market (By Chemical Formulations, By Applications, By End-users & By Surgery Stages) India Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 report at http://www.transparencymarketresearch.com/sterilizers-surgical-dental-care-equipment-disinfectors-market.html


The India sterilizers and surgical, dental care and equipment disinfectors market is segmented into the following categories:
 
Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market, by Chemical Formulations
Chlorhexidine Gluconate Based Formulations
Alcohol Based Agents
Povidone-Iodine Based Formulations
Benzalkonium Chloride Based Formulations
Octenidine Hydrochloride Based Formulations
Ethyl - hexadecyl - dimethyl Ammonium Based Formulations
Others (Aldehydes, Hydrogen Peroxide, Hypochlorites and Chlorine Based Disinfectors)
Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market, by Applications
Hospitals
General Hospitals
Wound Care
Burn Care
Ulcer Care
Dental Care Centers
Surgical Care
Diagnostic Care
Veterinary Care Centers
Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market, by End-users
Patients and Caregivers
Hospital and Nursing Staff
Operating Rooms, ICUs and Nursing Tables
Equipment and Devices used during Surgery
Others (Veterinary and Diagnostic Care Centers)
Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market, by Surgery Stages
Pre-operative
Intra-operative
Post-operative

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=4681

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Mr. Nachiket Ghumare
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

The global market for peptide therapeutics market derives much of its demand from the treatment of cancer and diabetes. The rising incidence of these diseases is making way for the advancement of peptide drugs, which in turn is propelling the global peptide therapeutics market. Additionally, the technical advancements in peptide drugs have resulted in a reduction in total production cost, fueling the production process of new peptide drugs.

Browse Full Global Peptide Therapeutics Market Report With Complete TOC @ http://www.transparencymarketresearch.com/peptide-therapeutics-market.html


On the other hand, API manufacturers are facing a tough challenge from the complex structure of peptides. Other than this, the lack of regulatory standards to arbitrate developments in peptide drugs is also hampering the growth of the peptide therapeutics market. However, biotech enterprises are identifying prospects for future growth in collaboration with major pharmaceutical firms across the globe.The global peptide therapeutics market is expected to expand at a CAGR of 2.8% during the period from 2014 to 2020 in order to reach US$23.7 billion by 2020. The market had reached a value of US$18.9 billion in 2013.

Market for Respiratory Disorders Poised to Grow at Highest CAGR between 2014 and 2020

Peptide therapeutics find application in the treatment of various kinds of ailments such as cardiovascular, nervous, gastrointestinal, respiratory, metabolism-related, in addition to cancer, various infections, and pain. The cancer market was the dominant application segment of the peptide therapeutics market in 2013. However, the respiratory disorder market segment is projected to develop at the highest CAGR during the period from 2014 to 2020 owing to the recent approval of lucinactant, sold under the brand name Surfaxin.

The global peptide therapeutics market is analyzed on three fronts: Route of administration, marketing status, and regional distribution of the global industry. Based on route of administration, parenteral and oral are the two segments of this market, while branded peptide therapeutics and generic peptide therapeutics are the segments of the global market on the basis of marketing status. The market for generic peptides is expected to do well in the next few years on account of patent expirations expected in the branded peptide market in the near future.

Asia Pacific to Report Highest Compound Annual Growth Rate from 2014 to 2020

Regionally, the global peptide therapeutics market is distributed among North America, Europe, Asia Pacific, and the Rest of the World, wherein the global market is dominated by the North American and European markets, which jointly occupy over 60% of the global market. However, in spite of the dominance of these regions in the global market, the peptide therapeutics market in Asia Pacific is poised to grow at the highest CAGR during the period from 2014 to 2020.The peptide therapeutics market in Asia Pacific is majorly driven by the rapid growth of this market in China, India, and Japan. The rise in economic stability and increased awareness pertaining to the treatment of various diseases are the major factors fueling the growth of the market in this region.

Browse Full Press Release Report: http://www.transparencymarketresearch.com/pressrelease/peptide-therapeutics-market.htm

Japan is the second largest market in the global individual pharmaceutical industry, whereas China and India have a huge population pool suffering from various diseases and ailments that are cured with the help of peptide therapeutics. These factors are expected to establish Asia Pacific as the most promising market for peptide therapeutics in the near future. China and India are also emerging as some of the largest peptide API suppliers in the world.

Amgen, Inc., Bachem Holding AG, AstraZeneca Plc, CordenPharma Int. GmbH, Ipsen S.A., Eli Lilly and Co., Lonza Group Ltd., Novartis AG, Merck & Co., Inc., Novo Nordisk A/S, Roche Holdings AG, PolyPeptide Group, Sanofi, Millennium Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., and Takeda Pharmaceutical Co. Ltd. are the major enterprises working in the global peptide therapeutics industry. The market is mostly concentrated as Takeda, Teva, and Novo Nordisk collectively hold more than 50% of the overall peptide therapeutics market.

The forthcoming patent expiry of Copaxone by Teva and Velcade by Millennium Pharma and the projected launch of their generic alternatives are expected to change the dynamics of the global peptide therapeutics market in the near future.

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=418

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector - such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

According to a new market report published by Transparency Market Research "Pet Food Market - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2021," the market was valued at USD 25,703.6 million in 2014, which is expected to reach USD 28,146.1 million by 2021, growing at a CAGR of 1.3%% from 2015 to 2021. In terms of volume, the pet food market in Europe was valued at 4,260.3 kg million in 2014 and is expected to reach 4,602.5 kg million by 2021, growing at a CAGR of 1.1% from 2015 to 2021.


Browse the full Pet Food Market - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2021 report at http://www.transparencymarketresearch.com/europe-pet-food-market.html

europe-pet-food-market

The europe pet food market in terms of pet type has been segmented into dog food, cat food and others. The cat food segment held the largest market share in Europe in 2014. Increasing demand for small pets is one of the major factors boosting the demand for cat food in Europe. Increasing awareness about pet health and rising demand for pet specific products are some of the major factors boosting the demand for pet food in Europe. However, the others segment including fish food, bird food and other reptiles is the fastest growing segment throughout the forecast period.

In addition, the pet food market can be further segmented on the basis of food types into: dry food, nutritious food, wet/canned food, snacks/treats and others. The dry food segment held the largest market share in the pet food market by food type. Ease of handling coupled with lower prices are the major factors boosting the demand in the dry food segment. In addition, added nutritional value is also fueling the demand for dry pet food. The nutritious food segment is the fastest growing segment in Europe. Increasing awareness about pet health is boosting the demand for nutritious pet food in this region.

The pet food market in Europe has been further segmented by country into: U.K., Germany, France, Italy, Spain, Netherlands and rest of Europe. U.K. is the largest market for pet food in Europe. Increasing trend for nuclear family and rising demand for pets are boosting the demand for pet food in U.K. Apart from this, increasing demand for pet specific products is also expected to boost the demand for pet food in Europe. Spain is the fastest growing market for pet food in Europe. Increasing disposable income is one of the major factors boosting the demand for pet food in Spain. However, Italy is expected to experience stable growth throughout the forecast period. The volume consumption of pet food in Italy is expected to decline in the forecast period. However, the revenue is expected to increase owing to increasing prices.

The pet food market is dominated by major manufacturers such as Mars Inc., Nestle S.A., Colgate-Palmolive Co., Affinity Petcare and Big Heart Pet Brands among others. However, the local players are still to enter these markets due to brand loyalty of the consumers.


Browse the full Press Release:http://www.transparencymarketresearch.com/pressrelease/europe-pet-food-market.htm

Europe Pet Food Market: By Pet Type
Dog Food
Cat Food
Others
Europe Pet Food Market: By Food Type
Dry Food
Wet Food/Canned Food
Nutritious Food
Snacks/Treats
Others
Europe Pet Food Market: By Country
U.K.
Germany
Italy
France
Spain
Netherlands
Rest of Europe

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4390


About Us

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Mr. Nachiket
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

The beer culture in Europe dates back to several centuries, and this alcoholic beverage today forms a crucial part of the economy of several countries. It is interesting to note that several global beer brands have their roots in Europe. Thus, the beer market in Europe continues to remain a dynamic space, where innovative products are essential to growth. While Germany and the UK contribute to a large share of the demand for beer in Western Europe, Russia and Ukraine have led to the creation of a burgeoning beer market in Eastern Europe.

Given that in Europe, the market for beer is already well established, it will register a meager CAGR of 2.4%. But even this modest growth rate could translate into massive revenues because of the sheer size of the market. The Europe beer market was estimated at US$ 17.01 billion as of 2014, and will likely be worth US$20.05 billion by the end of 2021.

Browse Full Europe Beer Market Report With Complete TOC @ http://www.transparencymarketresearch.com/europe-beer-market.html


Despite Alcoholic and Non-Alcoholic Substitutes, Beer Market in Europe to be Positively Influenced by Market Drivers

Since beer is an inherent part of the culture of several European nations, the consumption of this alcoholic beverage may not see a steep incline, but will certainly continue to grow at a steadfast pace. The three leading types of beers consumed in Europe are: Stout, lager and ale.

There are several market drivers at play in Europe's beer market. The greatest among these is the perceived health benefits offered by beer (only when consumed in quantities recommended by physicians). As evidenced in studies in the past, beer can help limit the level of cholesterol in blood and can also guard against kidney stone. These benefits, coupled with a general increase in the disposable income of European consumers, after suffering the impact of the economic slowdown, will prove beneficial to the Europe beer market.

Yet, the restraining effect of certain other factors on the beer market in Europe cannot be entirely discounted. Beer faces competition from other alcoholic drinks such as vodka, whiskey, wine, and rum. Moreover, competition from non-alcoholic beverages and drinks-such as carbonated drinks, dairy drinks, energy drinks, and coffee and tea-is also on
the rise.

Browse Full Press Release :http://www.transparencymarketresearch.com/pressrelease/europe-beer-market.htm



Imaginative Marketing Campaigns and Innovative Products are Recommended Strategies for Beer Companies in Europe

The only way in which beer companies can attain a competitive edge in Europe is by launching innovative and healthier products that catch the fancy of consumers. Imaginative marketing and advertising campaigns will also be important for players in the beer market in Europe to tap emerging markets in Eastern Europe. A number of countries here are developing rapidly and carry several opportunities, which if seized on time, can help companies improve their bottom line.

Since virtually every country in Europe has a distinct beer consumption culture, market players will have to study each market individually and formulate strategies that can be feasibly deployed. Creating a stronger distribution chain-especially in the emerging markets of Eastern Europe-is yet another requisite for growth.

Lager is the Leading Product in the Beer Market in Europe, While Germany is Largest Beer Consuming Country in the Region

Pegged to reach US$20.05 billion by 2021, lager was the largest product type within the beer market in Europe. The market for lager in Europe was estimated at US$17.01 billion in 2014. The segment is expected to post a CAGR of about 2.4% between 2015 and 2021.

Germany led all other countries in the Europe beer market with estimated revenues of US$36.22 billion as of 2014. The country's revenues are forecast to rise at a CAGR of 1.7% to touch US$40.65 billion by 2021.

Request A Brochure Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=4415

About Us

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Acidity regulators are pH controlling agents used to provide unique flavors to food or beverage items. These are also food additives used for increasing the shelf life of foods. Acidity regulators are used worldwide in the food industry. These ingredients alter and maintain the acidity and alkalinity levels in food. This factor helps in processing foods and helps preserve its taste and safety. Acidity regulators prevent growth of harmful bacteria that could endanger health when consumed. Acidity regulators are also thickening agents and used in fruit drinks, jams, jellies, and pie fillings among other food categories.

Browse the full Acidity Regulators Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2021 report at http://www.transparencymarketresearch.com/acidity-regulators-market.html

Market Growth Attributed to Increase in Use of Processed Food Containing Acidity Regulators

acidity-regulators-market

Globally, the acidity regulators market has been bolstered due to growing demand in the food industry. Increased need for acidity regulators in powdered fruit beverages and fruit flavored beverages is anticipated to spur market growth positively. Increased uptake of fruit butters, jams, and candies is expected to impact the market expansion of acidity regulators exponentially. Ready-to-drink beverages and processed foods have become a habit due to hectic lifestyles. Acidity regulators that are available with modern improved technologies can be an additional factor for market growth. However, the fact that acidity regulators can cause negative effects such as nausea, vomiting, and other complications could obstruct market growth. Low-cost suppliers of acidity regulators could also hinder market growth for larger players.


Browse the full Press Release Report: http://www.transparencymarketresearch.com/pressrelease/acidity-regulators-market.htm


Market to Expand with Acidity Regulators Being Used in Cosmetics and Skin Care Products

Growth estimates for the global acidity regulators market indicate that it had reached a value of US$3.93 billion in 2014 and is expected to reach US$6.34 billion by 2021, growing at a CAGR of 7.3%. The use of acidity regulators in non-food and new products such as skincare and cosmetics is expected to become a market opportunity. Acidity regulators are used as pH balancers in lotions and gels to be compatible with skin pH levels.

Citric Acid Leads Product Type Market Segment

The acidity regulators market product type segment includes acetic acid, lactic acid, phosphoric acid, malic acid, and citric acid. In 2014, citric acid had the largest market share and this trend is expected to continue during the next few years. By application, the acidity regulators market segments are: Confectionary, bakery, beverages, processed foods, sauces, dressings, and condiments.

By geography, acidity regulators market has been divided into segments such as North America, Europe, Asia Pacific, and Rest of the World (Row). The largest market share for acidity regulators was held by Asia Pacific and it is also estimated as a rapidly expanding market at a CAGR of 7.6% from 2015 to 2021, followed by North America. The rise in industrialization and urbanization in India, China and Indonesia is increasing demand for processed food. This is leading to market growth for acidity regulators in these regions. Rest of the World (RoW) follows Asia Pacific in market expansion prospects. The major players operating in the global acidity regulator market include Univar, Lyle plc., Jungbunzlauer A.G., Corbion N.V., Tate and Cargill Incorporated.


Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=4690


About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

According to a new market report published by Transparency Market Research "Alternative Sweetener Market - Global Industry Analysis, Size, Share, Growth and Forecast 2015 - 2021", global alternative sweetener market was valued at USD 11,538.6 million in 2014 and is expected to reach USD 15,466.7 million by 2021, growing at a CAGR of 4.2% from 2015 to 2021. North America dominated the global alternative sweetener market in terms of demand over the forecast period. Further, North America is expected to be the most promising market for alternative sweetener in the near future.

Browse the full Alternative Sweetener Market - Global Industry Analysis, Size, Share, Growth and Forecast 2015 - 2021 report at http://www.transparencymarketresearch.com/alternative-sweetener-market.html


The global alternative sweetener market is primarily driven by rise in demand for healthier low-calorie food and beverages. Furthermore, rising prices of sugar have boosted the growth of the alternative sweetener market. However, the restraining factor of the alternative sweetener market is the food and safety regulations and excess consumption of sugar substitutes which causes certain side effects such as cancer, obesity and cardiovascular diseases among others serious health problems.

The high intensity sweetener (HIS) held the largest market share in 2014. High intensity sweetener is expected to grow at a CAGR of 3.4% from 2015 to 2021. The high fructose syrup (HFS) held the second largest market share of alternative sweetener in 2014, followed by high intensity sweetener. The fastest growing market segment, low intensity sweetener in overall alternative sweetener market is expected to grow at a CAGR of 7.1% over the forecast period.

alternative-sweetener-market

North America is the market leader for alternative sweetener, growing at a CAGR of 3.6% from 2015 to 2021. Asia Pacific is the other major region where alternative sweetener sales are very high and the region is expected to grow with a stable CAGR, between 2015 to 2021, followed by Europe. In North America, the U.S. and Mexico dominated the market revenue for alternative sweetener. In Asia Pacific, China and India are the major markets growing at a CAGR of 3.4% and 6.0% respectively from 2015 to 2021. In Europe, Germany was the most attractive market of alternative sweetener in terms of revenue in 2014. Though Asia Pacific held the second position in global alternative sweetener market, and still it is expected to grow with a high CAGR as compare to Europe over the forecast period.

Tate & Lyle Plc, Cargill, Incorporated, Ajinomoto Co., Inc., Archer-Daniels-Midland Company, Ingredion Incorporated, Roquette Frères S.A., and NutraSweet Company are some of the key players operating in alternative sweetener market globally.

This research study is specially designed to estimate and analyze the demand and performance of alternative sweetener in a global scenario. Under the scope of the report, all the major product segments of the alternative sweetener market are covered. In addition, the report provides historical data, business strategies of major market players, statistically refined forecast and in-depth analysis for the segments covered. The research study provides detail analysis of alternative sweetener ingredients and alternative sweetener product manufacturers, sales of alternative sweetener based products and trend analysis by segments and demand by geography. The scope of the study presents a comprehensive evaluation of the stakeholder strategies and winning imperatives for them by segmenting the alternative sweetener market as below:


Browse Full Press Release :
http://www.transparencymarketresearch.com/pressrelease/alternative-sweetener-market.htm


Global alternative sweetener market has been segmented as follows:
Global alternative sweetener market, by product type
High Fructose Syrup (HFS)
High Intensity Sweetener (HIS)
Low Intensity Sweetener (LIS)
Global alternative sweetener market, by application
Food
Beverages
Others (including pharmaceuticals and personal care etc)
In addition, the report provides cross-sectional analysis of all the above segments with respect to the following geographies:
Global alternative sweetener, by geography
North America
U.S.
Canada
Rest of North America
Europe
Germany
U.K.
France
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
Rest of Europe
Rest of the World (RoW)
Latin America
Middle East
Other countries in RoW

Request a Brochure of this Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=4792


About Us

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Mr. Atil Chaudhari
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Ultra low molecular weight heparin (ULMWHs) Market, low molecular weight heparin (LMWHs) Market, unfractionated heparin Market, anticoagulants Market.According to a new market report published by Transparency Market Research Heparin Market - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2022", the Europe heparin market was valued at USD 2,004.5 million in 2013 and is expected to grow at a CAGR of 5.2% from 2014 to 2022, to reach an estimated value of USD 3,148.0 million in 2022.


Browse the full Heparin Market (Unfractionated Heparin, Low Molecular Weight Heparin & Ultra Low Molecular Weight Heparin) - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 report at http://www.transparencymarketresearch.com/europe-heparin-market.html

Heparin is a highly sulfated glycosaminoglycan sourced from animals, and used as an anticoagulant therapy in patients with blood clots and those undergoing surgery and dialysis. Heparin is generally available as an injection which need to be administered in presence of a healthcare practitioner. Its dosage depends on the medical condition of the patient, drug response and type of heparin. There are three types of heparin available in the European market namely unfractionated heparin, low molecular weight heparin (LMWH) and ultra-low molecular weight heparin (ULMWH). Low molecular weight heparin is the majorly used heparin type in Europe owing to its added advantage over unfractionated heparin. Low molecular weight heparins such as enoxaparin, dalteparin, tinzaparin and certoparin are the majorly sold heparin drugs in Europe.

europe-heparin-market


Unfractionated heparin is mainly used in hospitals and owing to its narrow therapeutic window and the possible risk of bleeding. Although, the effect of unfractionated heparin can be reversed using protamine sulphate, its use is diminishing owing to higher risk of osteopenia and thrombocytopenia. Therefore, researchers developed low molecular weight heparin which has lesser side effects and much safer compared to unfractionated heparin. Advent of low molecular weight heparin has decreased the market share of unfractionated heparin in Europe to less than 10% in 2013. Lovenox (enoxaparin) is a major brand in the LWMH market in Europe.

Further the advent of ultra-low molecular weight heparin in the European market has increased the market size of heparin products in this region. Arixtra (fondaparinux sodium) form GlaxoSmithKline plc is the major brand in Europe ULMWH market. Recently in 2012, Dr. Reddy's Laboratory Ltd. had filed for marketing approval of its biosimilar version of Arxitra in Europe which was refiled in 2013 post receipt of comments for the European regulatory authorities. Entry of biosimilars will augment the market growth in Europe. However, concerns pertaining to the quality of heparin post the contamination issue in 2008 has alerted the regulatory authorities in Europe emphasizing on the traceability of raw heparin. This factor has delayed the market entry for biosimilar heparins in the European market. Presence of many LMWH product makes it the dominant product segment in the European heparin market. Moreover, LMWH will grow at a faster CAGR of 5.6% during the forecast period owing to it high demand and cost effective therapeutic performance compared to other heparins.


Browse the full Press Release : http://www.transparencymarketresearch.com/pressrelease/europe-heparin-market.htm



The Europe Heparin Market is segmented into the following categories:

Europe Heparin Market, by Product
Unfractionated Heparin
Low Molecular Weight Heparin (LMWHs)
Ultra-low Molecular Weight Heparin (ULMWHs)
Europe Heparin Market, by Country
United Kingdom
Unfractionated Heparin
Low Molecular Weight Heparin (LMWHs)
Ultra-low Molecular Weight Heparin (ULMWHs)
Germany
Unfractionated Heparin
Low Molecular Weight Heparin (LMWHs)
Ultra-low Molecular Weight Heparin (ULMWHs)
France
Unfractionated Heparin
Low Molecular Weight Heparin (LMWHs)
Ultra-low Molecular Weight Heparin (ULMWHs)
Spain
Unfractionated Heparin
Low Molecular Weight Heparin (LMWHs)
Ultra-low Molecular Weight Heparin (ULMWHs)
Italy
Unfractionated Heparin
Low Molecular Weight Heparin (LMWHs)
Ultra-low Molecular Weight Heparin (ULMWHs)
Rest of the Europe
Unfractionated Heparin
Low Molecular Weight Heparin (LMWHs)
Ultra-low Molecular Weight Heparin (ULMWHs)

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=4815

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

The global food stabilizer market is expected to experience a stable growth throughout the forecast period. Food stabilizers maintain the stability of food products in term of texture, volume and mouth feel. The global food stabilizer market is segmented on the basis of application, function and geography. By application the food stabilizers market can be segmented into bakery, confectionary, dairy products, beverages, convenience food and others. The others segment includes processed meat and, sauces and condiments among others. By function the food stabilizers market has been segmented into stabilizing function, texturing function, and moisturing function among others. In addition, the report provides a cross-sectional analysis of all the above segments with respect to different geographical regions including North America, Europe, Asia Pacific and Rest of the World (RoW).

Browse the full Food Stabilizer MarketReport :
http://www.transparencymarketresearch.com/food-stabilizer-market.html


Increasing demand for convenience food is one of the major factors fuelling the demand for food stabilizers globally. Busy lifestyle and changing eating patterns are driving the growth of convenience food products and this in turn is fuelling the growth of the food stabilizer market. Moreover, owing to increasing demand for organic food products the global food stabilizer market is expected to experience stable growth throughout the forecast period. Food stabilizers are being added to the finished product in order to increase the shelf life and to maintain the overall quality of organic food products. Increasing health concerns of people across the globe is driving the market for organic food items which in turn is driving the growth of the food stabilizer globally. In addition, the use of food stabilizers gives competitive advantage to food industry over other market players since food stabilizers helps to impart the exact volume, mouth feel and texture demanded by consumers. Owing to this factor, the demand for food stabilizers is increasing and is expected to grow rapidly during the forecast period.

However, despite of the several factors driving the demand of food stabilizers, they can pose a serious threat if consumed within specified limit. There are several side effects associated with food stabilizers. Gelatin can cause allergic reactions. Alginate or algin which is used to increase the viscosity of a food product has an adverse effect in woman during pregnancy. Excessive consumption of guar gum increases the chances of gas production, loose motion and diarrhoea and various other complications. In addition, stringent government regulations across different countries restrain the growth of global food stabilizer market. Different organizations including FDA have set safety standards to determine whether a stabilizer is safe enough for its intended use. In spite of these restraining factors the food stabilizer market will stand firm during the forecasted period.

The conclusive analysis of the global food stabilizer market and the expected market growth for the period 2015 to 2021 is provided in this report. The report provides in depth study of different market segments and detailed analysis of the food stabilizer market across different segments based on application, function and by geography. This report also provides various macro and micro economic factor affecting the demand of food stabilizers.

Browse the full Press Release :http://www.transparencymarketresearch.com/pressrelease/food-stabilizer-market.htm

In the food stabilizer market, among application segment the dairy products held the largest market share in 2014. Increasing health concerns among the consumers is driving the market for diary food items which in turn is driving the growth of the food stabilizer market. Food stabilizers are being added to the diary product to increase the shelf life, to maintain the overall quality and to maintain nutritional stability of diary food products.

In 2014, across the geography, Europe held the largest market share i.e. 40.0% in the food stabilizer market. Europe is a mature market in term of food stabilizer due to its high penetration level in European market. Consequently the market growth of food stabilizers in European market is sluggish. Europe is followed by North America. Increasing working population and rising health consciousness among consumers is boosting the demand for dairy and ready to eat products, which in turn is driving the market for food stabilizer stabilizers. On the other hand economic development in developing countries such as India, China and Japan leads to an increase in disposable income which in turn increases the purchasing power of consumers. Owing to this change in lifestyle coupled with increasing disposable income people are looking for processed and ready to eat convenience food. The market growth of food stabilizers in this region is attributed to the increasing demand for these processed and ready to eat food.

Overall, the report provides a detailed analysis of the global food stabilizer and the expected growth for the period 2015 to 2021, after considering various macro and micro economic factors affecting the demand.

The report segments the food stabilizer market as:

By Application
Bakery
Confectionary
Dairy Products
Beverages
Convenience Food
Others
By Function
Stabilizing Function
Texturing Function
Moisturing Function
Others
By Geography
North America
U.S.
Canada
Mexico
Europe
U.K.
France
Germany
Italy
Others
Asia-Pacific
India
China
Japan
Others
Rest of the World (RoW)
Middle East
Latin America
Africa


Request A Brochure Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=b&rep_id=5006

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Cooking oils and fats form an imperative part of a healthy diet. Dietary fat is imperative for human health. Saturated fats increase the cholesterol level in a human body while Monounsaturated and Polyunsaturated fats tend to lower the cholesterol level in the human body. Food and drinks contain several essential nutrients, fats being one of them. Some food and drinks contain a large number of only one nutrient such as fried foods, which contain a large number of fat and soft drinks, which contain a large number of sugar. Dietary fat is imperative for many body processes. Dietary fat helps circulating some essential vitamins around the human body and helps in making hormones.

Browse the full Cooking Oils and Fats Market Report at http://www.transparencymarketresearch.com/cooking-oils-fats-market.html


The increasing demand for cooking oils and fats in emerging markets such as India, Indonesia and Argentina is the major factor that is pushing the demand for the cooking oils and fats market. The increase in the disposable income of the consumers and the increasing busy lifestyle of the consumer is also another reason which is fuelling the demand for processed foods and ready to drink beverages across the world. This factor, in turn is fuelling the demand for cooking oils and fats market globally. In addition, increasing use of high quality edible oils associated with the moderate consumption of oils and fats is also another major factor that is fuelling the demand for the global cooking oils and fats market.

Excessive consumption of fats and oils pose as a major threat to the global cooking oils and fats market. A lot of processed foods such as Pizzas, French Fries, and Doughnuts contain a large number of trans fats which is not good human health, if consumed on a regular basis. The consumption of trans fats raises the LDL in the human body. In addition, consumption of trans fats increase the incidences of several heart diseases, type 2 diabetes and cancer). Moreover, the high price of raw materials makes it difficult for any new player trying to enter the cooking oils and fats market.

Suitable alternatives for trans fats is expected to serve as an opportunity for the oils and fats
market across the world.

Wilmar International Ltd., Unilever plc, Associated British Foods plc, Ajinomoto Co. Inc, CHS Inc are some of the major players that are operating in the global cooking oils and fats market.

The report has been segmented by product type, and geography and it includes drivers, restraints and opportunities (DRO's), Supply Chain analysis of the cooking oils and fats market. The study highlights current market trends and provides forecasts from 2015 to 2021. We have featured the current market scenario for the global cooking oils and fats market and identified future trends that will impact demand for cooking oils and fats during the forecast period.

Browse the full Press Release:http://www.transparencymarketresearch.com/pressrelease/cooking-oils-fats-market.htm

By product, the market has been segmented into Vegetable and Seed Oil, Spreadable Oils and Fats, Butter, Margarine, Olive Oil and Cooking Fats. By geography, the market has been segmented into North America, Europe, Asia-Pacific and Rest of the World (Row). The report provides the current market size and anticipates its status over the forecast period.

The report also analyzes factors driving and inhibiting growth in the cooking oils and fats market. The report will help manufacturers, suppliers, and distributors to understand the present and future trends in this market and formulate strategies accordingly.

The report segments the cooking oils and fats market as:

Global Cooking Oils and Fats Market, by Product Type
Vegetable and Seed Oil
Spreadable Oils and Fats
Butter
Margarine
Olive Oil
Cooking Fats
Global Cooking Oils and Fats Market, by Geography
North America
U.S.
Rest of North America
Europe
Germany
U.K.
France
Italy
Rest of Europe
Asia Pacific
China
India
Rest of Asia Pacific
Rest of the World (RoW)
Brazil
U.A.E.
South Africa
Others


Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=5003

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

The global tuberculosis testing market continues to grow as governments and institutions across the globe continue to make efforts to eradicate this deadly communicable disease. Statistics gathered by the WHO state that 9 million people acquired tuberculosis (TB) in 2013 and 1.5 met a fatal end, out of which 360,000 were HIV positive. These figures are declining with each passing year thanks to the increasingly effective diagnosis and treatment options offered to patients. It is estimated that such initiatives were able to save the lives of 37 million tuberculosis patients between 2000 and 2013.

Browse Full Global Tuberculosis Testing Market Report With Complete TOC @ http://www.transparencymarketresearch.com/tuberculosis-testing-market.html


Tuberculosis can be broken down into two types, namely active disease, which can transform to multi-drug resistant TB or MDR-TB, and latent disease. Tuberculosis also has a rare form called miliary TB, which occurs when TB infection finds its way to the bloodstream. The priority steps to counter MDR-TB are supreme quality of treatment for drug-susceptible TB to avert MDR-TB, expanding the reach of testing and detection of MDR-TB cases to remote regions, simplifying the access to good healthcare, infection control, and strengthening the political commitment, especially in BRIC nations, which constitute 50% of global TB cases.

Dedicated Efforts of Non-profit Organizations Drive Global Tuberculosis Testing Market

The efforts taken by governments, social activists, and several healthcare institutions have translated into positive results. A ripple effect of these efforts can also be seen in the growth of the global tuberculosis testing market. The global tuberculosis testing market was worth US$1,936.1 million in 2013. By 2020 this market is expected to reach a valuation of US$2,619.4 million, growing at a promising CAGR of 4.3% from 2014 to 2020.

The factors driving this gigantic growth are the rising number of tuberculosis cases, increasing acceptance of innovative methods for treating tuberculosis, and enhanced molecular and rapid culture diagnostic tests. The serious involvement and dedicated efforts of non-profit healthcare organizations are further boosting the global tuberculosis testing market. Growing tuberculosis cases have also resulted in increased research and development budgets, encouraging manufacturers to launch better testing technologies.

Serological Tests and IGRA Sub-segments to Grow the Fastest

The global tuberculosis testing market is classified on the basis of type and geography. The segments by product type are culture-based tests, smear microscopy, nucleic acid testing, radiography (chest x-ray), Mantoux test (tuberculin skin test), drug susceptibility test (DST), and other tests such as serological tests, ADA, and IGRA. Geographically, the global tuberculosis testing market is fragmented into North America, Asia Pacific, Europe, and Rest of the World.


Browse Full Press Release report http://www.transparencymarketresearch.com/pressrelease/tuberculosis-testing-market.htm

Out of these segments, culture-based tests hold a lion's share in the global tuberculosis testing market. These tests are inclusive of both solid and liquid culture tests. Analysts predict that other segments such as serological tests and IGRA will grow rapidly in the coming five years as well. All of these tuberculosis testing methods generate quick results, offer improved accuracy, and require the patient to just one visit.

India and China to Make Steady Contribution to Growth of Global Tuberculosis Market

Geographically, Asia Pacific led the global tuberculosis testing market in 2013, closely followed by North America. The prime factor driving the unprecedented growth rate in Asia Pacific is a huge patient pool, which continues to grow at a rapid rate, especially in countries such as China and India. Though North America has a smaller patient pool, the tuberculosis testing market is expected to grow in this region due to increasing awareness, better healthcare infrastructure, and growing acceptance and adoption of expensive TB tests due to improving purchasing power of patients.

Some of the key players in the global tuberculosis testing market are Akonni Biosystems Inc., Abbott Laboratories, Becton, Alere Inc., Dickinson and Company, Cepheid, Epistem plc, bioMérieux SA, F. Hoffmann-La Roche Ltd., Hologic, QIAGEN, Hain Lifescience GmbH, Sanofi, and Thermo Fisher Scientific Inc.

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=2267



About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Forage feed refers to food that is consumed by grazing animals. Traditionally, forage only meant plants such as crop residue, pasture, or immature cereal crops that were eaten by animals. However, as the global forage feed market grows to provide quality feed to livestock, there is a variety of forage feed in the market that is being sold through retailers. Companies are looking at ways to enhance forage feed in order to increase its nutritional value, resulting in increased milk production at dairy farms.

Browse Full Global Forage Feed Market Report With Complete TOC @ http://www.transparencymarketresearch.com/forage-feed-market.html

Today, manufacturers produce forage feed out of green feed, herbaceous legumes, grass, tree legumes, silage, and hay. Forage feed not only contributes to the benefit of livestock production and their output, but it also helps in conserving the environment to a great extent. Forage feed is a vital aid to production of food crop by conserving soil, wildlife, landscape, curbing pollution, and reclaiming and revegetating degraded areas. It also acts as a source of high quality proteins for many pharmaceutical and medical products.

The global forage feed market is segmented on the basis of products, type of livestock, and region. The product segment of the global forage feed market includes fresh forage, stored forage, and others. Depending on the livestock, the global forage feed market is fragmented into pork or swine, poultry, aquaculture, cattle, and others. Geographically, the global forage feed market is divided into North America, Europe, Asia Pacific, and Rest of the World. The best kind of forage is fresh forage as it provides the livestock with high quality nourishment and is considered to be palatable feed. Stored forage such as hay is chopped and packed in plastic bags.

Increasing Meat Consumption Fuels the Global Forage Feed Market

The global forage feed market was valued at US$85.06 billion in 2013 and will reach US$162.87 billion by 2019, growing a CAGR of 11.4% from 2013 to 2019. In terms of volume the forecast growth rate is a CAGR of 9.2%. This high growth rate is largely fueled by increasing meat consumption across the globe, rising awareness about the health benefits of forage feed for animals, and growing farm animal population.

Forage Feed Substitutes Hinder the Growth

Despite the presence of strong growth factors, the global forage feed market has a tough road ahead. The availability of a wide range of substitutes is the biggest threat to this market. Due to lack of funds and support from governments, poultries prefer these substitutes over high quality forage feed; thus stealing the limelight from the forage feed market in certain regions. Additionally, lack of funds for research and development activities in the global forage feed market is also hindering the growth of this sector.

Browse Full Presss Release :http://www.transparencymarketresearch.com/pressrelease/forage-feed-market.htm

Asia Pacific Holds the Biggest Market Share

In terms of region, Asia Pacific leads the global forage feed market with a share of 41.51% in 2013. The biggest contributors to this growth are countries such as Japan, India, China, and Japan. The Asia Pacific region is expected to register a growth rate of 11.8% during the forecast period, making it the best performing regional segment of the global forage feed market. Europe closely followed Asia Pacific in 2013 with a market share of 28.1% in terms of revenue generation.

Some of the key players of the global forage feed market are The Pure Feed Company Limited, Cargill Incorporated, Triple Crown Nutrition Inc., Standlee Hay Company Inc., Baileys Horse Feeds, Semican Inc., and J. Grennan and Sons. The action plans of these companies will decide the future growth of this market in the global economy.

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=1654

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.


Contact:
Mr.Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/